Frontier of Medical Expertise
Developing novel drugs is an important part of modern medicine. Each year, the Food and Drug Administration (FDA) evaluates and approves a few dozen new drugs-latest therapeutic breakthroughs in the related disease areas. FDA approvals help set new standard of care and significantly advance patient treatments. Patients, in the United States and globally, benefit from having access to the safe and advanced therapeutic breakthroughs.
This Year’s FDA Approvals and Their Related Disease Areas
This year’s FDA approvals and their related disease areas represent most recent therapeutic breakthroughs and frontier of medical expertise. In 2020, the Center for Drug Evaluation and Research (CDER) at FDA approved 53 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biologics under Biologics License Applications (BLAs). The novel drug therapies-those never before approved or marketed in the United States-are approved for 47 diseases or health conditions from seven categories, including Infectious Disease; Neurology; Autoimmune, Inflammatory, and Lung Diseases; Heart, Blood, Kidney, and Endocrine Diseases; Cancers ; and Other Advances, Other Rare Diseases.
Diseases are categorized in accordance to New Drug Therapy Approvals 2020 Advancing Health Through Innovation (FDA, 2021 )
America’s Top Hospitals on Medical Expertise
Behind latest therapeutic breakthroughs are America’s top hospitals, especially teaching hospitals and academic medical centers! They help propel the frontier of medical expertise, with tremendous devotion to decade-long studies in clinical practice, scientific research, and translational investigation.
According to the American Hospital Association, there are a total of 6,146 hospitals in the United States, including ~1,300 teaching hospitals and ~400 academic medical centers.
Search for the Best of the Best
This year's America's top hospitals for medical expertise celebrates their unique contribution to each disease behind the FDA approved drugs in the past year, by rating their specific expertise for the breakthrough diseases. Novel drugs are innovative products that often serve previous unmet medical needs, enhance patients treatment options, and set standard of care in related disease areas. America's top hospitals represent the best of the best for the medical expertise.
In total, 24 hospitals from 19 cities from 17 states were identified for the expertise evaluation, representing the top 4‰ of all hospitals, or 6% of academic medical centers in the United States.
